Jack Satsangi

机构：Centre for Human Genetics, Nuffield Orthopaedic Centre, John Radcliffe Hospital, University of Oxford, Oxford University Hospitals NHS Trust

发表论文 577 篇 · 总被引 44434 次 · h-index 87

代表论文

• SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease (2023 · Nature Medicine · 被引 137)
• Challenges in IBD Research 2024: Precision Medicine (2024 · Inflammatory Bowel Diseases · 被引 42)
• Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial (2024 · The Lancet Rheumatology · 被引 30)
• Current and emerging biomarkers for ulcerative colitis (2023 · Expert Review of Molecular Diagnostics · 被引 30)
• Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III region (2024 · EBioMedicine · 被引 26)
• Composition of plant-based diets and the incidence and prognosis of inflammatory bowel disease: a multinational retrospective cohort study (2025 · The Lancet Regional Health - Europe · 被引 23)